UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 415

Sortiert nach

Role of OATP transporters in steroid uptake by prostate cancer cells in vivo

Prostate cancer and prostatic diseases, 2017-03, Vol.20 (1), p.20-27

2017

Volltextzugriff (PDF)

A novel vascular endothelial growth factor, VEGF‐C, is a ligand for the Flt4 (VEGFR‐3) and KDR (VEGFR‐2) receptor tyrosine kinases

The EMBO journal, 1996-01, Vol.15 (2), p.290-298

1996

Volltextzugriff (PDF)

Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells

The Journal of biological chemistry, 1994-03, Vol.269 (9), p.6271-6274

1994

Volltextzugriff (PDF)

VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development

Development (Cambridge), 1996-12, Vol.122 (12), p.3829-3837

1996

Volltextzugriff (PDF)

Expression of the Fms-Like Tyrosine Kinase 4 Gene Becomes Restricted to Lymphatic Endothelium During Development

Proceedings of the National Academy of Sciences - PNAS, 1995-04, Vol.92 (8), p.3566-3570

1995

Volltextzugriff (PDF)

Vascular Endothelial Growth Factor B, a Novel Growth Factor for Endothelial Cells

Proceedings of the National Academy of Sciences - PNAS, 1996-03, Vol.93 (6), p.2576-2581

1996

Volltextzugriff (PDF)

Conceptual spaces: elaborations and applications

1st ed. 2019., 2019

Volltextzugriff (PDF)

Expression of vascular endothelial growth factor and placenta growth factor in human placenta

Biology of reproduction, 1997-02, Vol.56 (2), p.489-494

1997

Volltextzugriff (PDF)

A novel vascular endothelial growth factor, VEGF‐C, is a ligand for the Flt4 (VEGFR‐3) and KDR (VEGFR‐2) receptor tyrosine kinases

The EMBO journal, 1996-04, Vol.15 (7), p.1751-1751

1996

Volltextzugriff (PDF)

Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors

The American journal of pathology, 1995-02, Vol.146 (2), p.368-378

1995

Volltextzugriff (PDF)

The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells

The Journal of experimental medicine, 1993-12, Vol.178 (6), p.2077-2088

1993

Volltextzugriff (PDF)

Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype

The Journal of clinical investigation, 2004-11, Vol.114 (9), p.1260-1271

2004

Volltextzugriff (PDF)

Dose-Dependent Response of FGF-2 for Lymphangiogenesis

Proceedings of the National Academy of Sciences - PNAS, 2004-08, Vol.101 (32), p.11658-11663

2004

Volltextzugriff (PDF)

Evidence by Molecular Profiling for a Placental Origin of Infantile Hemangioma

Proceedings of the National Academy of Sciences - PNAS, 2005-12, Vol.102 (52), p.19097-19102

2005

Volltextzugriff (PDF)

PPARγ as a therapeutic target for tumor angiogenesis and metastasis

Cancer biology & therapy, 2005-07, Vol.4 (7), p.687-693

2005

Volltextzugriff (PDF)

Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic Mice

Science (American Association for the Advancement of Science), 1997-05, Vol.276 (5317), p.1423-1425

1997

Volltextzugriff (PDF)

Micro-mechanical forces stimulate proliferation of perfused tissues

Journal of plastic, reconstructive & aesthetic surgery, 2007, Vol.60 (4), p.S14-S14

2007

Volltextzugriff (PDF)

Lymphangiogenesis New Mechanisms

Annals of the New York Academy of Sciences, 2002-12, Vol.979 (1), p.111-119

2002

Volltextzugriff (PDF)

ZD6474, a Novel Tyrosine Kinase Inhibitor of Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor, Inhibits Tumor Growth of Multiple Nervous System Tumors

Clinical cancer research, 2005-11, Vol.11 (22), p.8145-8157

2005

Volltextzugriff (PDF)

The rationale for nonsteroidal anti-inflammatory drug therapy for inflammatory myofibroblastic tumors: a Children's Oncology Group study

Journal of pediatric surgery, 2005-06, Vol.40 (6), p.999-1003

2005

Volltextzugriff (PDF)

Genes tell lymphatics to sprout or not

Nature immunology, 2004-01, Vol.5 (1), p.11-12

2004

Volltextzugriff (PDF)

Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3

Cancer research (Chicago, Ill.), 1998-04, Vol.58 (8), p.1599-1604

1998

Volltextzugriff (PDF)

Therapeutic potential of thiazolidinediones as anticancer agents

Expert opinion on investigational drugs, 2003-12, Vol.12 (12), p.1925-1937

2003

Volltextzugriff (PDF)

Mechanics of interstitial-lymphatic fluid transport: theoretical foundation and experimental validation

Journal of biomechanics, 1999-12, Vol.32 (12), p.1297-1307

1999

Volltextzugriff (PDF)

Expression of Mad, an antagonist of Myc oncoprotein function, in differentiating keratinocytes during tumorigenesis of the skin

British journal of cancer, 1996-06, Vol.73 (11), p.1347-1355

1996

Volltextzugriff (PDF)

1 – 25 von 415

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(253)
Mit Volltextzugriff
(301)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Role of OATP transporters in steroid uptake by prostate cancer cells in vivo

A novel vascular endothelial growth factor, VEGF‐C, is a ligand for the Flt4 (VEGFR‐3) and KDR (VEGFR‐2) receptor tyrosine kinases

Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells

VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development

Expression of the Fms-Like Tyrosine Kinase 4 Gene Becomes Restricted to Lymphatic Endothelium During Development

Vascular Endothelial Growth Factor B, a Novel Growth Factor for Endothelial Cells

Conceptual spaces: elaborations and applications

Expression of vascular endothelial growth factor and placenta growth factor in human placenta

A novel vascular endothelial growth factor, VEGF‐C, is a ligand for the Flt4 (VEGFR‐3) and KDR (VEGFR‐2) receptor tyrosine kinases

Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors

The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells

Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype

Dose-Dependent Response of FGF-2 for Lymphangiogenesis

Evidence by Molecular Profiling for a Placental Origin of Infantile Hemangioma

PPARγ as a therapeutic target for tumor angiogenesis and metastasis

Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic Mice

Micro-mechanical forces stimulate proliferation of perfused tissues

Lymphangiogenesis New Mechanisms

ZD6474, a Novel Tyrosine Kinase Inhibitor of Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor, Inhibits Tumor Growth of Multiple Nervous System Tumors

The rationale for nonsteroidal anti-inflammatory drug therapy for inflammatory myofibroblastic tumors: a Children's Oncology Group study

Genes tell lymphatics to sprout or not

Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3

Therapeutic potential of thiazolidinediones as anticancer agents

Mechanics of interstitial-lymphatic fluid transport: theoretical foundation and experimental validation

Expression of Mad, an antagonist of Myc oncoprotein function, in differentiating keratinocytes during tumorigenesis of the skin

Suchergebnisse filtern